Sigyn Therapeutics Inc (SIGY): Frustrating to say the least. No informa...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Wednesday, 09/19/2018 3:41:41 PM

Wednesday, September 19, 2018 3:41:41 PM

Frustrating to say the least. No information really out from the company about next steps and where they are headed. The revenues are not doing well.

Keep Last Read

Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 01/31/2024 09:20:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:23:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 08:25:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 07:34:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 07:48:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 07:23:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 09:10:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 07:56:11 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:35:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 03:15:11 PM
Sigyn Therapeutics Discloses "DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES" Patent Submission and Related ImmunePrep™ Trademark Application • InvestorsHub NewsWire • 05/17/2023 11:15:02 AM

InvestorsHub NewsWire

Only $200 per official company press release!